Han-Wei Lin
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2
- Immunology 11
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 2
- Co-authors
- Wen‐Fang Cheng (19 shared papers)Chi‐An Chen (15 shared papers)Yu‐Li Chen (16 shared papers)Ming‐Cheng Chang (9 shared papers)Ying‐Cheng Chiang (10 shared papers)Wei‐Zen Sun (11 shared papers)Chang‐Yao Hsieh (2 shared papers)Chi-Fang Chang (7 shared papers)
- Journals
- Cancer Letters (3 papers)Bulletin of Environmental Contamination and Toxicology (2 papers)Cancers (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Molecular Therapy (1 paper)
- Partner nations
- TaiwanUnited StatesAustria
In The Last Decade
Han-Wei Lin
29 papers receiving 830 citations
Peers
Comparison fields: 5 of 110
- Reproductive Medicine 117
- Immunology 266
- Oncology 334
- Cancer Research 95
- Biotechnology 41
Countries citing papers authored by Han-Wei Lin
This map shows the geographic impact of Han-Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-Wei Lin more than expected).
Fields of papers citing papers by Han-Wei Lin
This network shows the impact of papers produced by Han-Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-Wei Lin. The network helps show where Han-Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Han-Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 128 | |
| 2 | 2011 | 116 | |
| 3 | 2019 | 75 | |
| 4 | 2008 | 75 | |
| 5 | 2019 | 50 | |
| 6 | 2018 | 41 | |
| 7 | 2017 | 39 | |
| 8 | 2021 | 38 | |
| 9 | 2015 | 33 | |
| 10 | 2012 | 31 | |
| 11 | 2005 | 25 | |
| 12 | 2013 | 22 | |
| 13 | 2018 | 22 | |
| 14 | 2004 | 21 | |
| 15 | 2023 | 20 | |
| 16 | 2018 | 16 | |
| 17 | 2019 | 14 | |
| 18 | 2004 | 13 | |
| 19 | 2018 | 13 | |
| 20 | 2018 | 9 |
About Han-Wei Lin
Han-Wei Lin is a scholar working on Oncology, Immunology, Molecular Biology, Reproductive Medicine and Health, Toxicology and Mutagenesis, having authored 30 papers that have together received 839 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Ovarian cancer diagnosis and treatment (6 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Research and Treatments (2 papers), Neuropeptides and Animal Physiology (2 papers), CAR-T cell therapy research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Reproductive Medicine (117 citations), Immunology (266 citations), Oncology (334 citations), Cancer Research (95 citations) and Biotechnology (41 citations). Han-Wei Lin has collaborated with scholars based in Taiwan, United States and Austria. Frequent co-authors include Wen‐Fang Cheng, Chi‐An Chen, Yu‐Li Chen, Ming‐Cheng Chang, Ying‐Cheng Chiang, Wei‐Zen Sun, Chang‐Yao Hsieh, Chi-Fang Chang, C. L. Chien and Chia‐Yen Huang. Their work appears in journals such as Cancer Letters, Bulletin of Environmental Contamination and Toxicology, Cancers, Journal for ImmunoTherapy of Cancer and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.